Inhaled epoprostenol during one-lung ventilation

Karthik Raghunathan; Neil Roy Connelly; Larry D Robbins; Rose Ganim; Gary Hochheiser; Rebecca DiCampli

doi:10.1016/j.athoracsur.2009.07.059

Inhaled epoprostenol during one-lung ventilation

Ann Thorac Surg. 2010 Mar;89(3):981-3. doi: 10.1016/j.athoracsur.2009.07.059.

Authors

Karthik Raghunathan¹, Neil Roy Connelly, Larry D Robbins, Rose Ganim, Gary Hochheiser, Rebecca DiCampli

Affiliation

¹ Department of Anesthesiology, Baystate Medical Center, Tufts University School of Medicine, Springfield, Massachusetts 01199, USA. karthik.raghunathan@bhs.org

PMID: 20172177
DOI: 10.1016/j.athoracsur.2009.07.059

Abstract

We used inhaled epoprostenol (with intravenous phenylephrine) during one-lung ventilation to improve oxygenation in a patient with severe interstitial lung disease undergoing video-assisted thoracoscopic surgery. The pharmacologic manipulation of pulmonary blood flow remains an underused strategy for the management of hypoxemia during one-lung ventilation.

Publication types

Case Reports

MeSH terms

Administration, Inhalation
Biopsy*
Epoprostenol / administration & dosage*
Humans
Infusions, Intravenous
Lung / pathology*
Lung Diseases, Interstitial / diagnosis
Male
Middle Aged
Nebulizers and Vaporizers
Phenylephrine / administration & dosage
Pulmonary Circulation / drug effects
Respiration, Artificial / methods*
Thoracic Surgery, Video-Assisted*
Vasodilator Agents / administration & dosage*

Substances

Vasodilator Agents
Phenylephrine
Epoprostenol